In HCC cells, loss of LCAD has been shown to promote tumor progression as a consequence of the activation of Yap [21] or reduction of phosphatase and tensin homolog [20], while overexpression of LCAD has been shown to inhibit tumor growth [20], indicating that LCAD has tumor-suppressive functions. The gene discussed is ACADL; the disease is hepatocellular carcinoma.